66 related articles for article (PubMed ID: 30563166)
1. Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.
Nascimento AV; Gattacceca F; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Nanomedicine (Lond); 2016 Apr; 11(7):767-81. PubMed ID: 26980454
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.
Bi YY; Chen Q; Yang MY; Xing L; Jiang HL
Nat Commun; 2024 Mar; 15(1):2759. PubMed ID: 38553451
[TBL] [Abstract][Full Text] [Related]
4. Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan-Fucoidan Nanoparticles.
Choi DG; Venkatesan J; Shim MS
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262038
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA.
Sandhiutami NMD; Arozal W; Louisa M; Rahmat D; Wuyung PE
Front Pharmacol; 2020; 11():603235. PubMed ID: 33536913
[TBL] [Abstract][Full Text] [Related]
6. In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy.
Luo Z; Wan Z; Ren P; Zhang B; Huang Y; West RE; Huang H; Chen Y; Nolin TD; Xie W; Wang J; Li S; Sun J
Adv Sci (Weinh); 2024 May; 11(19):e2307940. PubMed ID: 38482976
[TBL] [Abstract][Full Text] [Related]
7. Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells.
Sorasitthiyanukarn FN; Muangnoi C; Gomez CB; Suksamrarn A; Rojsitthisak P; Rojsitthisak P
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839794
[TBL] [Abstract][Full Text] [Related]
8. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.
Tang C; Liu J; Yang C; Ma J; Chen X; Liu D; Zhou Y; Zhou W; Lin Y; Yuan X
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358986
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer
Cheng M; Dai D
Front Oncol; 2022; 12():971475. PubMed ID: 35992879
[TBL] [Abstract][Full Text] [Related]
10. Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease.
Lee YS; Oh SM; Li QQ; Kim KW; Yoon D; Lee MH; Kwon DY; Kang OH; Lee DY
Curr Issues Mol Biol; 2022 Jan; 44(1):409-432. PubMed ID: 35723408
[TBL] [Abstract][Full Text] [Related]
11. Curcuminoids Inhibit Angiogenic Behaviors of Human Umbilical Vein Endothelial Cells via Endoglin/Smad1 Signaling.
Chou YF; Lan YH; Hsiao JH; Chen CY; Chou PY; Sheu MJ
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409247
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.
Haider M; Elsherbeny A; Pittalà V; Consoli V; Alghamdi MA; Hussain Z; Khoder G; Greish K
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163777
[TBL] [Abstract][Full Text] [Related]
13. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice
Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132
[TBL] [Abstract][Full Text] [Related]
14. Advances in Chitin and Chitosan Science.
Fenice M; Gorrasi S
Molecules; 2021 Mar; 26(6):. PubMed ID: 33806913
[TBL] [Abstract][Full Text] [Related]
15. Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway.
Chen Y; Hong C; Chen X; Qin Z
Oncol Lett; 2020 Nov; 20(5):209. PubMed ID: 32963615
[TBL] [Abstract][Full Text] [Related]
16. The roles of curcumin in regulating the tumor immunosuppressive microenvironment.
Wang Y; Lu J; Jiang B; Guo J
Oncol Lett; 2020 Apr; 19(4):3059-3070. PubMed ID: 32256807
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines.
Bonaccorsi PM; Labbozzetta M; Barattucci A; Salerno TMG; Poma P; Notarbartolo M
Pharmaceuticals (Basel); 2019 Oct; 12(4):. PubMed ID: 31717764
[TBL] [Abstract][Full Text] [Related]
18. Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.
Chen YY; Lin YJ; Huang WT; Hung CC; Lin HY; Tu YC; Liu DM; Lan SJ; Sheu MJ
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563166
[TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways.
Lin CY; Hung CC; Wang CCN; Lin HY; Huang SH; Sheu MJ
Phytomedicine; 2019 Feb; 53():28-36. PubMed ID: 30668408
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
